Factors Affecting Completion of Human Papillomavirus Vaccination Series by Gender in a Predominantly Hispanic Border Town Community. Issue 2 (8th April 2023)

• Record Type: Journal Article
• Authors: Calderón-Mora, Jessica; Lara, Hatty; Hernandez, Blanca; Molokwu, Jennifer
• Is Part Of: Journal of lower genital tract disease. Volume 27:Issue 2(2023)
• Page Start: 161
• Page End: 167
• Publication Date: 2023-04-08
• Subjects: human papillomavirus vaccine -- vaccine completion -- Hispanic or Latino -- health disparities -- acculturation -- health belief model; Generative organs, Female -- Diseases -- Periodicals; Cervix uteri -- Diseases -- Periodicals; Generative organs -- Diseases -- Periodicals; Sexually transmitted diseases -- Periodicals; 618.1
• DOI: 10.1097/LGT.0000000000000728
• Languages: English
• ISSNs: 1089-2591

Abstract

Abstract : No statistically significant human papillomavirus vaccine series completion rates, by sex, were found in a US-Mexico border community. Abstract : Objectives: The human papillomavirus (HPV) vaccine is recommended for females and males aged 9 to 45. Nationally, the HPV vaccination rates are lower for males than females; however, this has not been studied in a US-Mexico border community. Our study aims to report the HPV vaccination completion by gender and determine which sociodemographic factors influence vaccination. Methods: This cross-sectional study was conducted among uninsured and underinsured individuals aged between 9 and 26 years served through a community-based HPV vaccine program in El Paso, TX. Data collected included demographic information, psychosocial variables, and vaccine administration data. Descriptive statistics were used to summarize demographic data. Unadjusted t test/Fisher exact test and multivariable relative risk regression were run on significant variables to determine the association with vaccine completion by gender. Results: Most participants were female (63.4%), and an overall vaccine series completion was 30.67%. We found no significant difference in HPV vaccine completion rates by gender. Males who resided in the United States for more than a decade were 31% more likely to complete the vaccine series, and females who had 9 to 13 years of education had lower odds of vaccine completion. Knowledge significantly increased after the intervention for both genders ( p = .002). There was no significant change in psychosocial variables from the preintervention to the immediate postintervention survey. Conclusions: Our multicomponent, culturally tailored intervention may equally impact male and female participants and encourages all genders to complete their HPV vaccine series. Additional studies with a larger male sample are needed.